Sign Up to like & get
recommendations!
3
Published in 2023 at "Pediatrics"
DOI: 10.1542/peds.2022-060894
Abstract: OBJECTIVES We assessed BNT162b2 vaccine effectiveness (VE) against mild to moderate and severe coronavirus disease 2019 (COVID-19) in children and adolescents through the Omicron BA.4/BA.5 period. METHODS Using VISION Network records from April 2021 to…
read more here.
Keywords:
bnt162b2 covid;
effectiveness bnt162b2;
waning 150;
150 days ... See more keywords